Advanced Cancer Genetic Testing and Oncogenetics Services

Advanced genetic insights for precision oncology. Our cancer genetic testing identifies inherited risks to guide personalised treatment and improve patient outcomes.
Book a Consultation
A vector banner image of a man discussing with a medical professional for assessing male reproductive genetic health.
A vector image illustrating sperm DNA fragmentation.

Understanding Oncogenetics

Oncogenetics focuses on how genetic mutations and chromosomal alterations influence cancer development, progression, and response to therapy. As a specialised genetic testing center, we recognise that understanding the genetic blueprint of a tumour or an individual’s predisposition is essential for modern cancer care.

By integrating advanced genomic technologies and cancer genetic testing into clinical practice, oncologists can better identify high-risk individuals and recommend personalised treatment strategies tailored to the specific molecular profile of the disease.

Cancer gene panel testing in the field of oncogenetics can help:

  • Identify hereditary risks for individuals and their families.
  • Guide the selection of targeted therapies and immunotherapies.
  • Monitor treatment response and detect early signs of recurrence.
  • Provide accurate prognostic information for various cancer types.

Who Can Benefit from Hereditary Genetic Testing for Cancer?

Our oncogenetics lab services and clinical evaluations may be recommended for:

Individuals with a strong family history of cancer (especially early-onset).

Patients recently diagnosed with cancer seeking targeted therapy options.

Individuals interested in hereditary genetic testing for cancer to assess lifetime risk.

Patients who have not responded to standard chemotherapy protocols.

Family members of individuals known to carry pathogenic genetic variants.

Clinicians who require comprehensive genomic profiling for complex or rare cases.

Genetic testing provides valuable insights that help patients and clinicians make more informed, data-driven treatment choices.

Discover Our Oncogenetics Testing Services

The oncogenetics hub provides specialised testing services essential for supporting precision diagnosis, treatment selection, and long-term surveillance. These services identify the specific genetic factors driving cancer growth.

BRCA1 & BRCA2 Testing

BRCA1 BRCA2 testing is essential for assessing the risk of hereditary breast and ovarian cancer syndromes. These results guide preventive measures and determine eligibility for specific targeted treatments like PARP inhibitors.

HRR — Somatic & Germline Testing

HRR somatic germline testing evaluates mutations in the homologous recombination repair pathway. Understanding these variants is critical for identifying patients who may benefit from specific DNA-damaging therapies.

Comprehensive Genomic Profiling (CGP) + TMB + MSI

Comprehensive genomic profiling typically analyses hundreds of cancer-related genes simultaneously. By including Tumour Mutational Burden (TMB) and MSI microsatellite instability testing, we provide a complete roadmap for immunotherapy and targeted drug selection.

Liquid Biopsy Cancer Testing

Liquid biopsy cancer testing offers a non-invasive way to detect circulating tumour DNA (ctDNA) from a simple blood draw. This is ideal for monitoring treatment resistance and detecting recurrence earlier than conventional methods in certain cases.

OncoFocus 52 Gene Panel

The OncoFocus 52 gene panel is a targeted NGS assay designed to identify actionable mutations across common solid tumours, providing rapid results to guide first-line treatment decisions.

OnKoSeq 161 Panel

A broader screening tool, the OnKoSeq 161 panel covers a wide range of DNA and RNA variants, offering an extensive look at the molecular drivers of various malignancies.

Hereditary Cancer Gene Panels

Beyond BRCA, our cancer gene panel testing covers multiple high-risk genes associated with Lynch syndrome, Li-Fraumeni syndrome, and other inherited cancers to protect at-risk family members.

MSI (Microsatellite Instability) Testing

MSI microsatellite instability testing is a key biomarker for Lynch syndrome and a primary indicator for predicting response to PD-1/PD-L1 checkpoint inhibitors.

Cytogenetics for Oncology

Our lab provides specialised cytogenetic analysis, including BCR/ABL translocation for leukaemia and specific markers for sarcoma, helping in precise disease classification.

Our Approach to Oncogenetics

At Anderson Genetics, our cancer genetic testing services are supported by world-class molecular diagnostics and the latest genomic platforms.

Our integrated approach includes

  • Next-Generation Sequencing (NGS) for multi-gene analysis.
  • Advanced bioinformatics for precise variant interpretation.
  • Comprehensive Somatic and Germline integration.
  • High-precision liquid biopsy cancer monitoring.
  • Dedicated clinical genetic expertise and oncology support.

This multidisciplinary approach helps clinicians and patients navigate the complexities of cancer genetics with absolute confidence.

Vector illustration for Sperm Aneuploidy testing.
A DNA Structure
An inquiry for a Male Reproductive Genetic Health testing appointment is illustrated.

Start Your Oncogenetics Journey

Whether you are seeking a risk assessment, a second opinion, or a personalised treatment plan, our genomic insights provide the clarity you need. Our team of experts is here to support you with the most advanced oncogenetics lab services available.
Contact Our Genetics Team

Frequently Asked Questions (FAQs)

What is cancer genetic testing?

Cancer genetic testing identifies specific mutations in your DNA that may cause cancer or allow it to grow. It includes testing for inherited risks (germline) and mutations within the tumour itself (somatic).

Why is BRCA1 BRCA2 testing important?

BRCA1 BRCA2 testing helps determine if you have a significantly higher risk of developing certain cancers. It also helps doctors choose specific medications that are proven to work better for BRCA-positive patients.

What is the benefit of a liquid biopsy?

Liquid biopsy cancer testing is a blood-based test that avoids the need for invasive tissue biopsies. It is highly effective for monitoring how a tumour changes during treatment.

How does Comprehensive Genomic Profiling (CGP) help?

Comprehensive genomic profiling looks at the entire landscape of the tumour. It helps find “hidden” mutations that standard tests might miss, opening up new possibilities for clinical trials and targeted therapies.

Is my data secure in your oncogenetics lab?

Yes. As a specialised genetic lab, we maintain the highest standards of data privacy and medical ethics, ensuring your genomic information is handled with the utmost confidentiality.